BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30985051)

  • 21. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study.
    Ishii K; Kinoshita T; Kiridume K; Watanabe A; Yamakawa K; Nakao S; Fujimi S; Matsuoka T
    Scand J Trauma Resusc Emerg Med; 2019 Feb; 27(1):25. PubMed ID: 30819212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
    Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
    Tsujimoto T; Kajio H
    Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procoagulant state in heart failure with preserved left ventricular ejection fraction.
    Jug B; Vene N; Salobir BG; Sebestjen M; Sabovic M; Keber I
    Int Heart J; 2009 Sep; 50(5):591-600. PubMed ID: 19809208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of the dosing, a 12-week physical training on the concentration of NT-proBNP and D-Dimer in patients with heart failure and impaired functional capacity in VII-X decade of life].
    Andrzejczak-Karbowska M; Irzmański R
    Pol Merkur Lekarski; 2016 Jul; 41(241):11-15. PubMed ID: 27734814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.
    Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K; Ko YA; Aida H; Hesaroieh I; Mahar E; Kim JH; Wilson P; Shaw L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
    Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
    Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Tang WHW; Grodin J; Passino C; Emdin M
    Circulation; 2018 Jan; 137(3):286-297. PubMed ID: 29335288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
    Grodin JL; Testani JM; Pandey A; Sambandam K; Drazner MH; Fang JC; Tang WHW
    Eur J Heart Fail; 2018 Oct; 20(10):1436-1443. PubMed ID: 29893446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
    Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
    J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.